CGH Medical Center Not Associated with Meningitis Outbreak
STERLING, IL, October 17, 2012 – Earlier this week, the FDA added more drugs to the watch list for fungal meningitis outbreak. CGH Medical Center would like to continue to reassure its patients, that there is no risk of exposure at the hospital or any of its clinics.
The announcement included links to more products made by the New England Compounding Center (NECC).
“Our patient’s safety is our number one priority,” said William Bird, MD, Clinic Medical Director, “and [we] want to assure everyone that the products we are using are completely safe.”
STERLING, IL, October 9, 2012 – With the recent reports of an outbreak of meningitis associated with potentially contaminated steroid medication, CGH Medical Center would like to reassure its patients who have received steroid injections at the hospital or any of its satellites, that there is no risk of exposure.
The Centers for Disease Control (CDC) has tied the outbreak to steroid shots for back pain. The patients were injected in their spine with a preservative-free steroid called methylprednisolone acetate. The steroid was made by a specialty pharmacy in Massachusetts that did not nor does not supply steroid injections for CGH Medical Center, CGH Main Clinic or any CGH outlying clinics.
“CGH Pharmacy has not purchased any steroid products from NECC (New England Compounding Co.),” said Tim Dunphy, RPh, CGH Director of Pharmacy.
According to the CDC, 72 facilities in 23 states received the products from the company that produced the steroid. The three locations in Illinois are near Chicago.
“We just want to assure all of our patients that there is no risk of exposure from steroid products given by CGH or any of our satellites clinics,” said William Bird, MD, Clinic Medical Director. “Our patient’s safety is our number one priority, and want to assure everyone that the products we are using are completely safe.”
The Food and Drug Administration is urging anyone who has experienced problems to report it to MedWatch, the agency's voluntary reporting program, by phone at 1-800-FDA-1088 or online at www.accessdata.fda.gov/scripts/medwatch/medwatch-online.htm.
The outbreak should not keep people from having procedures that are already planned. If you have any further questions, please contact your physician.